Novo Nordisk A/S banner

Novo Nordisk A/S
NYSE:NVO

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
NYSE:NVO
Watchlist
Price: 38.5799 USD -1.25% Market Closed
Market Cap: $171.8B

Wall Street
Price Targets

NVO Price Targets Summary
Novo Nordisk A/S

Wall Street analysts forecast NVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVO is 57.9514 USD with a low forecast of 42.1916 USD and a high forecast of 89.3803 USD.

Lowest
Price Target
42.1916 USD
9% Upside
Average
Price Target
57.9514 USD
50% Upside
Highest
Price Target
89.3803 USD
132% Upside
Novo Nordisk A/S Competitors:
Price Targets

Revenue
Forecast

12% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 3 years is 2%.

Operating Income
Forecast

13% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
13% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's operating income is 13%. The projected CAGR for the next 3 years is 3%.

Net Income
Forecast

14% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat
14% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's net income is 14%. The projected CAGR for the next 3 years is 1%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVO's stock price target?
Price Target
57.9514 USD

According to Wall Street analysts, the average 1-year price target for NVO is 57.9514 USD with a low forecast of 42.1916 USD and a high forecast of 89.3803 USD.

What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
2%

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 3 years is 2%.

What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
3%

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's operating income is 13%. The projected CAGR for the next 3 years is 3%.

What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
1%

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's net income is 14%. The projected CAGR for the next 3 years is 1%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett